Sodium Glucose Cotransporter-2 Inhibitors as an Add-on Therapy to Metformin Plus Dipeptidyl Peptidase-4 Inhibitor in Patients with Type 2 Diabetes

PURPOSE: To date, no study has compared the effects of adding sodium glucose cotransporter-2 (SGLT-2) inhibitors to the combination of metformin plus dipeptidyl peptidase-4 (DPP-4) inhibitors to the effects of adding other conventional anti-diabetic drugs (ADDs) to the dual therapy. We aimed to comp...

Descripción completa

Detalles Bibliográficos
Autores principales: Bae, Jaehyun, Kim, Young-eun, Lee, Minyoung, Lee, Yong-ho, Lee, Byung-Wan, Cha, Bong-Soo, Kang, Eun Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Yonsei University College of Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171674/
https://www.ncbi.nlm.nih.gov/pubmed/35619577
http://dx.doi.org/10.3349/ymj.2022.63.6.539

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9171674/
https://www.ncbi.nlm.nih.gov/pubmed/35619577
http://dx.doi.org/10.3349/ymj.2022.63.6.539

Ejemplares similares